Buying guide
Apple Watch vs Stelo in 2026
Comparing 2 humanoid robots across availability, pricing, capabilities, and verified deployments. Current as of 2026.
Key differences
On DEPLOY's record, Stelo has more verified real-world deployments (2 versus 1) than Apple Watch as of 2026; DEPLOY counts a deployment only when confirmed at a named site with a primary source.
- Apple Watch has more capabilities independently verified as autonomous (3 vs 0).
- Stelo has the lower recorded price.
- Stelo has more verified real-world deployments (2 vs 1).
| Attribute | ||
|---|---|---|
| Manufacturer | Apple | Dexcom |
| Form factor | biometric | biometric |
| Maturity | commercial | commercial |
| Autonomy | ✓ 3 verified autonomous | — |
| Availability | shipping-nowshipping | shipping-nowshipping |
| Price | $399-$799 (actual sale price) | $89-$99 (actual sale price) |
| Capability claims |
| — |
| Brain | — | — |
| Verified deployments | 1Apple | 2Dexcom, Dexcom |
| Privacy practices | 13cloud-upload, third-party-sharing, location-tracking, on-device-processing, training-data-use, data-sale, data-retention, biometric-storage, data-deletion-control, data-sale, data-deletion-control, data-retention, biometric-storage | 4biometric-storage, training-data-use, third-party-sharing, data-deletion-control |
| Sources on file | 27 | 12 |
Track this matchup
Get told the moment Apple Watch or Stelo changes. Verified changes only, the second they are real. No press-release noise.
Apple Watch
Stelo
Editorial summaries
Apple Watch
The Apple Watch (current Series 11 and Ultra 3, September 2025; Series 9/10 and Ultra 2 supported) is a biometric-primary smartwatch and the canonical reference of the biometric cohort, with the broadest FDA-cleared portfolio: ECG and AFib/irregular-rhythm notifications (De Novo 2018), sleep-apnea notifications (2024), and hypertension notifications (2025), plus fall and crash detection and the Vitals app. Its sensors (optical PPG, electrical ECG, temperature, accelerometer/gyro, blood-oxygen) need no subscription for the FDA-cleared medical features.
Pricing anchors at about $399 for the Series base (aluminum, GPS), with the Ultra around $799 and the SE around $249 (the SE lacks ECG). A within-entity verified-vs-claimed exemplar: blood-oxygen was disabled in the US in January 2024 over the Masimo ITC ruling and re-enabled in August 2025 via a paired-iPhone calculation redesign. DEPLOY holds the claims to the specific cleared indications: these are cleared features with defined scope, not a general cardiac or sleep diagnostic.
Stelo
Dexcom's Stelo is the first-ever FDA-cleared over-the-counter (no-prescription) glucose biosensor (De Novo, March 5, 2024; US launch August 26, 2024): a 15-day continuous glucose monitor for adults 18+ not on insulin (type 2 not on insulin, plus non-diabetic users tracking how diet and exercise affect glucose). It is the generative-AI end of the glucose cell: Weekly Insights run on Google Cloud's Vertex AI and Gemini, with AI photo meal-logging and personalized daily recommendations, the AI substance that carries it across the biometric boundary.
Pricing is about $89 for a 2-week sensor on a biweekly subscription model (around $99/month). From DexCom (NASDAQ: DXCM), Stelo is the OTC product line, separate from the prescription G7. Cap-flag: the cleared indication is an OTC CGM for adults 18+ not on insulin; it is explicitly NOT cleared for problematic hypoglycemia and has no low-glucose alerts, so it should not be read as a diabetes-management device.
Common questions
How do Apple Watch and Stelo differ?
What is the difference between Apple Watch and Stelo?
Which is cheaper, Apple Watch or Stelo?
Is Apple Watch or Stelo more autonomous?
Which has more verified deployments, Apple Watch or Stelo?
Recent coverage
- Apple Watches With Ceramic Finish Reportedly Returning This YearApple Watch · CNET – Technology · 2026-08-20
- Win an Apple Watch – Round 3 of CNET’s Guessing Game Is Live NowApple Watch · CNET – Technology · 2026-08-18
- Dexcom’s latest executive pay disclosure covers new CEO’s big yearStelo · Medical Design & Outsourcing · 2026-06-15
- Will Giving Everyone a Blood Sugar Monitor Lead to Better Health Outcomes? Maybe, But Only If We Tell People What to Do With The InfoStelo · The Spoon · 2026-01-15
Related comparisons
- Lingo vs Apple Watch
- Apple Watch vs Fitbit (Charge / Sense / Versa)
- Apple Watch vs Garmin (Venu / Fenix / Forerunner)
- Apple Watch vs Happy Ring
- Apple Watch vs Evie Ring (and EvieMED)
- Apple Watch vs Oura Ring 4
- Apple Watch vs Pixel Watch
- Apple Watch vs RingConn (Gen 2 / Gen 3)
- Apple Watch vs Samsung Galaxy Ring
- Apple Watch vs Samsung Galaxy Watch (and Galaxy Ring)
- Apple Watch vs Ultrahuman Ring (Air / Pro)
- Apple Watch vs Whoop (5.0 / MG)
Keep researching
Keep reading
Ask the registry
For AI assistants
Use DEPLOY in Claude, Cursor, and other AI assistants
Connect any MCP-aware assistant to the live registry. Ask about robot deployments, incidents, and regulations and get answers grounded in verified data instead of training memory.
Machine-readable: this page as markdown.

